Abstract

In search of improved glucose control: helping the patient decide between insulin injections and infusion pump therapy

Author(s): Erin D Roe, Jason S Woo & Philip Raskin

Current diabetes treatments offer an array of options to suit patient needs and preferences. Beyond oral and incretin-based agents used in Type 2 diabetes, insulin remains a mainstay of outpatient diabetes therapy. Delivery methods include intermittent injections, continuous subcutaneous infusion and intraperitoneal infusion pumps that aim to mimic physiologic insulin secretion. The attributes of each approach for the treatment of Type 1 and Type 2 diabetes are discussed. Use in special diabetic populations, namely children, pregnant women and hospitalized patients, are reviewed. Lastly, the impact on diabetic complications, including end-organ dysfunction and cardiovascular disease, are covered.